1. Home
  2. BUDA vs RANI Comparison

BUDA vs RANI Comparison

Compare BUDA & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BUDA

Buda Juice Inc. Common Stock

N/A

Current Price

$8.81

Market Cap

110.1M

ML Signal

N/A

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.06

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BUDA
RANI
Founded
2013
2012
Country
United States
United States
Employees
39
N/A
Industry
Beverages (Production/Distribution)
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.1M
126.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BUDA
RANI
Price
$8.81
$1.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$14.00
$7.50
AVG Volume (30 Days)
6.6K
874.2K
Earning Date
03-26-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.14
EPS
N/A
N/A
Revenue
N/A
$1,633,000.00
Revenue This Year
N/A
$274.77
Revenue Next Year
N/A
$79.44
P/E Ratio
$24.42
N/A
Revenue Growth
N/A
58.85
52 Week Low
$7.61
$0.39
52 Week High
$10.70
$3.87

Technical Indicators

Market Signals
Indicator
BUDA
RANI
Relative Strength Index (RSI) 42.15 54.54
Support Level $8.90 $0.46
Resistance Level $10.42 $1.10
Average True Range (ATR) 0.51 0.09
MACD -0.09 0.01
Stochastic Oscillator 39.49 69.27

Price Performance

Historical Comparison
BUDA
RANI

About BUDA Buda Juice Inc. Common Stock

Buda Juice Inc operates in a beverage industry, focused on fresh, cold-crafted juice production for business-to-business (B2B) distribution. The Company mostly utilizes third-party delivery systems and operates within the State of Texas serving large, national chain grocery stores. It is pioneering a new category in beverages-UltraFresh juice-offering cold-crafted citrus-based drinks that are never heat-treated, pasteurized, never HPP- processed, never UV- treated and always cold.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: